Business Description
ImmunoPrecise Antibodies Ltd
NAICS : 325412
SIC : 3741
ISIN : CA45257F2008
Description
ImmunoPrecise Antibodies Ltd is a biotechnology company that leverages multi-omics modeling and complex artificial intelligence through a series proprietary and patented technologies. The company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies and are known for solving very complex industry challenges.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.24 | |||||
| Equity-to-Asset | 0.55 | |||||
| Debt-to-Equity | 0.49 | |||||
| Debt-to-EBITDA | -0.67 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -3.31 | |||||
| Beneish M-Score | -3.54 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -7 | |||||
| 3-Year EBITDA Growth Rate | -111.7 | |||||
| 3-Year EPS without NRI Growth Rate | -5.6 | |||||
| 3-Year FCF Growth Rate | -18 | |||||
| 3-Year Book Growth Rate | -27.1 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 65.32 | |||||
| Future 3-5Y Total Revenue Growth Rate | 19.51 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 57.72 | |||||
| 9-Day RSI | 52.65 | |||||
| 14-Day RSI | 48.26 | |||||
| 6-1 Month Momentum % | -56.11 | |||||
| 12-1 Month Momentum % | -60.2 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.99 | |||||
| Quick Ratio | 0.82 | |||||
| Cash Ratio | 0.35 | |||||
| Days Inventory | 65.98 | |||||
| Days Sales Outstanding | 50.39 | |||||
| Days Payable | 127.37 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -12 | |||||
| Shareholder Yield % | -38.13 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 48.22 | |||||
| Operating Margin % | -60.1 | |||||
| Net Margin % | -114.33 | |||||
| FCF Margin % | -29.11 | |||||
| ROE % | -61.41 | |||||
| ROA % | -39.05 | |||||
| ROIC % | -22 | |||||
| ROC (Joel Greenblatt) % | -182.56 | |||||
| ROCE % | -47.66 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.59 | |||||
| PB Ratio | 0.46 | |||||
| Price-to-Tangible-Book | 9.4 | |||||
| EV-to-EBIT | -0.93 | |||||
| EV-to-EBITDA | -1.15 | |||||
| EV-to-Revenue | 1.14 | |||||
| EV-to-Forward-Revenue | 1.07 | |||||
| EV-to-FCF | -3.91 | |||||
| Earnings Yield (Greenblatt) % | -107.53 | |||||
| FCF Yield % | -44.61 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
ImmunoPrecise Antibodies Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 16.442 | ||
| EPS (TTM) (€) | -0.722 | ||
| Beta | 0 | ||
| Volatility % | 39.88 | ||
| 14-Day RSI | 48.26 | ||
| 14-Day ATR (€) | 0.049239 | ||
| 20-Day SMA (€) | 0.3662 | ||
| 12-1 Month Momentum % | -60.2 | ||
| 52-Week Range (€) | 0.284 - 2.28 | ||
| Shares Outstanding (Mil) | 28.83 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
ImmunoPrecise Antibodies Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
ImmunoPrecise Antibodies Ltd Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
ImmunoPrecise Antibodies Ltd Frequently Asked Questions
What is ImmunoPrecise Antibodies Ltd(STU:TQB)'s stock price today?
The current price of STU:TQB is €0.38. The 52 week high of STU:TQB is €2.28 and 52 week low is €0.28.
When is next earnings date of ImmunoPrecise Antibodies Ltd(STU:TQB)?
The next earnings date of ImmunoPrecise Antibodies Ltd(STU:TQB) is 2024-12-10.
Does ImmunoPrecise Antibodies Ltd(STU:TQB) pay dividends? If so, how much?
ImmunoPrecise Antibodies Ltd(STU:TQB) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers